Introduction
Uterine cervical cancer is the second most common cancer in women worldwide. Certain genotypes of human papillomavirus (HPV) have been shown to be closely associated with the development of cervical cancer. Currently, more than 90 different HPV genotypes have been identified. Genotypes HPV-16, -18, -31, -33, -35, -39, -45, -51, -52, -56, -58, -59 and -66 are regarded as highrisk types because they are identified in high-grade squamous intraepithelial lesions (HSILs) and invasive cervical cancer tissues [1, 2] . On the other hand, the genotypes HPV-6 and HPV-11 are considered as low-risk types [2] . Today, HPV genotyping information is clinically useful for the prognosis and therapy based on the risk [3] .
The frequency of HPV genotypes detected in cervical cancer tissues varies according to several factors, including the method of HPV detection and the ethnicity. More sensitive and reliable methods rather than individual testing, such as polymerase chain reaction (PCR), restriction fragment length polymorphism and Southern blot, should be developed as screening tools for HPV detection. Conventional methods of individual detection of each genotype have been replaced by a high-throughput technology which can identify many HPV genotypes at once. In the present study, a DNA array-based method to detect 25 different HPV genotypes, containing the 12 high-risk types, was applied in order to detect multiple HPV infection. A recent study revealed that multiple HPV infection is a factor implicated in persistent HPV infection [4] . Some studies also indicated that persistent HPV infection is critically implicated in the development of cervical dysplasia [4, 5] . Collectively, multiple HPV infection is likely to be associated with the development of cervical neoplasm. However, the prevalence of multiple HPV infection in invasive cervical cancer in Japan has not been elucidated. The quality of the template DNA is an important factor that can affect HPV genotyping results. Fresh specimens can yield DNA of better quality than formalin-fixed and paraffin-embedded tissues for amplification. Therefore, this study used fresh-frozen tissue specimens from consecutive patients newly diagnosed as having invasive cervical cancer and applied an HPV-DNA array to clarify the multiple HPV infection status.
Materials and Methods

Patients
A total of 60 invasive cervical cancers were obtained from archives of fresh-frozen tissues between the years of 1999 and 2004 at the Department of Gynecology of Hokkaido University, Sapporo, Japan. Forty-nine surgical specimens were obtained by radical hysterectomy. Eleven biopsy specimens were taken from patients who received radiotherapy and/or platinum-based chemotherapy as the initial treatment. In both cases, 5-mm 3 ). Each 4 ng of the amplified HPV-DNA and G3PDH sequence was purified using a spin column, and then blotted onto Hybond-N+ membrane (Amersham Biosciences, Tokyo, Japan). The schema of the HPV-DNA array is shown as online supplementary figure 1.
Genomic DNA was extracted from fresh-frozen tissues of 60 invasive cervical cancers using PureGene DNA isolation kit (Qiagen, Tokyo, Japan) and stored at -2 ° C until use. For probe labeling, genomic DNA templates (100 ng) were amplified, using 26 sets of primers (including the primer sets for 25 HPV genotypes and G3PDH, final 0.1 m M each, online suppl. table 1) and biotinylated dUTP (Roche Diagnostics, Tokyo, Japan). The cycle sequence was as follows: denaturation at 95 ° C for 20 s, annealing at 52 ° C for 30 s, and extension at 72 ° C for 30 s (25 cycles) followed by incubation at 72 ° C for 5 min. The labeled probes were purified using a spin column and stored at -20 ° C until use. The array membrane was prehybridized with PerfectHyb solution (Toyobo, Osaka, Japan) for 1 h at 72 ° C. Then, the labeled probes (biotin-incorporated PCR products) were denatured, and then hybridized with the membrane. Hybridization was done at 72 ° C for more than 12 h followed by highly stringent washes at 72 ° C. Signal detection was performed using the Phototope-Star Detection kit for nucleic acids (New England Biolabs, Ipswich, Mass., USA) and CDP-star (Roche Diagnostics) according to the manufacturers' protocols. Finally, chemiluminescent signals were measured using VersaDoc3000 system (BioRad Laboratories, Tokyo, Japan).
Statistical Analysis
The correlation between the status of HPV infection and the clinicopathological factors, including age, clinical stage, histology and lymph node metastasis, was examined. For statistical analysis, the 2 test or Fisher's exact test was used. p values ! 0.05 were considered to be significant. Statistical analyses were performed with Statview software (SAS Institute, Cary, N.C., USA). fig. 1 ) . Although further improvement is needed to prevent the cross-hybridization, we applied the HPV-DNA array for this study because HPV-20 and HPV-21 are skin-type HPVs.
Genotypes Detected in Invasive Cervical Cancer Tissues by the HPV-DNA Array
Representative results of HPV detection in cervical cancer tissues by the HPV-DNA array are shown in figure 2 . Data were considered to be valid only when the positive control signals of G3PDH were seen. All positive signals were validated by direct sequencing (data not shown). Table 2 summarizes the distribution of HPV genotypes according to histology. HPV was positive in 59 of 60 cases (98.3%). Among high-risk types, HPV-16, -18, -31, -33, -35, -52, and -58 were detected. The most prevalent genotype was HPV-16 (50/60, 83.3%), followed by HPV-18 (27/60, 45.0%) and HPV-52 (17/60, 28.3%). The prevalence of HPV-18 was significantly greater in Non-Sq (14/18, 77.8%) than in Sq (13/42, 31.0%) (p = 0.0008). HPV-52 and HPV-58 were observed exclusively in Sq. Among the lowrisk types, HPV-11 (17/60, 28.3%) and HPV-34 (8/60, 13.3%) were detected.
Correlation between Multiple High-Risk HPV Infection and Clinicopathological Factors
In the present study, 47 of 60 patients (78.3%) showed multiple HPV infection, in which the rate was much higher than the rates described previously [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] ( table 3 ). Among the 47 patients, multiple high-risk HPV infection was observed in 42 patients (42/60, 70.0%, table 4 ). To improve our understanding of the clinical significance of multiple high-risk HPV infection in invasive cervical cancer, the correlation between the status of multiple high-risk HPV infection and various clinicopathological factors was examined. Multiple high-risk HPV infection was observed in 14 of 15 (93.3%) patients below 40 years old, and in 28 of 45 (62.2%) patients 40 years of age and over. The difference in the positivity rate was statistically significant (p = 0.03). Multiple high-risk HPV infection was not associated with clinical stage (Ib/II versus III/IV, p = 0.95), histology (Sq versus Non-Sq, p = 0.71), and status of lymph node metastasis (negative versus positive, p = 0.73).
Discussion
HPV infection is considered a major causal factor of anogenital malignant lesions. Currently, more than 90 different HPV genotypes have been identified. The difficulty in HPV genotyping is due to the sequence homology of the viral genome, which will cause cross-hybridization with the Southern blot technique or unspecific amplification with the PCR method. Although DNA sequencing technology is able to distinguish each HPV genome sequence, it will require a lot of time and laboratory effort. Comprehensive HPV detection systems, including DNA array-based detection technology, may solve these problems. The HPV-DNA array system used in this study is a specific method to detect 25 different HPV genotypes without any significant cross-hybridization ( fig. 1 ) .
The International Agency for Research on Cancer reported that the top 5 prevalent HPV genotypes in invasive cervical cancer were HPV-16 (53%), HPV-18 (15%), HPV-45 (9%), HPV-31 (6%), and HPV-33 (3%) [24] . In this study, the top 5 prevalent HPV genotypes were HPV-16 (83.3%), HPV-18 (45.0%), HPV-52 (28.3%), HPV-31 (15.0%), and HPV-58 (13.3%). The high prevalence of HPV-16 and HPV-18 in Japanese patients with invasive cervical cancer is similar to the worldwide prevalence. The prevalence of HPV-18 was in this study was high as well. This may be attributed to the high proportion of adenocarcinoma in our patients because HPV-18 is closely associated with cervical adenocarcinoma rather than Sq [24] . Correspondingly, the prevalence of HPV-18 was significantly higher in Non-Sq (14/18, 77.8%) than in Sq (13/42, 31.0%) in the present study. On the other hand, the high prevalence of HPV-52 and HPV-58 in invasive Sq is a common finding in East Asia, including China, Hong Kong, Korea and Japan, compared to Western countries [24] .
The most important issue in this study is that the prevalence of multiple HPV infection in Japanese patients with invasive cervical cancer is extremely high (47/60, 78.3%). The reported incidence of multiple HPV infection in invasive cervical cancer varies greatly and ranges G3PDH ( z ) . The templates were amplified using the 26 sets of primers (including the primer sets for the 25 HPV genotypes and G3PDH ) and biotinylated dUTP. The labeled probes were hybridized with the array membranes, and then signals were detected as described in the Materials and Methods section. Most primer sets were specific for the corresponding template DNA though some cross-hybridization was seen between HPV-20 and HPV-21. between 1.5 and 39.6% [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . This result is, at least in part, due to the high sensitivity of the HPV-DNA array system and probably to the good quality of the template DNA used in this study. The DNA array system used in this study can detect 50 fg of the HPV genomic DNA; therefore, it can detect the signal if more than 5 copies of the genotype virus are present (online suppl. fig. 2 ). In addition, fresh-frozen samples were employed in this study, though other researchers mostly used formalinfixed and paraffin-embedded tissues. It is well known that the duration of fixation and the type of fixative used affect the quality of the extracted nucleic acids. Degradation of DNA is the most common type of damage. Although a comparative study is needed to determine whether the frequency of multiple HPV infection in invasive cervical cancer in Japan is higher than that in other countries, our data suggest that the 'true' positivity rate of multiple HPV infection in invasive cervical cancer might be higher than that expected from previous reports.
The clinical significance of multiple HPV infection remains to be elucidated. Ho et al. [4] investigated the natural history of cervicovaginal HPVs and found an association between the presence of multiple HPV genotypes and the persistence (over 6 months) of infection. On the contrary, other studies showed that persistent HPV infection was independent of coinfection with other HPV genotypes [25, 26] . The carcinogenic risk of multiple HPV infection is also controversial among reports. Lee et al. [27] reported that patients infected with multiple HPV genotypes had a 31.8-fold higher risk of cervical cancer while those infected with a single HPV genotype had a 19.9-fold increased risk. On the other hand, Sasagawa et al. [8] reported that the odds ratio of multiple HPV infection was 24 for low-grade squamous intraepithelial lesions, 16 for HSILs, and 8.3 for Sq of the cervix. The correct answer to the question about the association between multiple HPV infection and the pathogenesis of the disease may have to await further large-scale studies. In conclusion, our study demonstrated the high frequency of multiple HPV infection in Japanese patients with invasive cervical cancer, especially women below 40 years old. It would be worth establishing whether the presence of multiple HPV infection in the uterine cervix would be a marker for persistent HPV infection and progression of HPV-related diseases in the future. 
